Long COVID
Outcome unclear
Long COVID with insomnia, dysautonomia, PEM and MCAS; extreme sensitivity to low-dose LDN
- Condition
- Long COVID
- At worst
- Not stated
- Ill for
- Not stated
- Last post
- May 2026
In their words
- Condition: Long COVID
Very similar to my experience
In context ↗
Read from 1 of their posts and comments; links to the one this page draws on
Summary
Lagoon 20986 described insomnia, dysautonomia, PEM, MCAS and fatigue issues, and extreme sensitivity to low doses of medications and supplements. A 0.01 mg dose of LDN was enough to worsen all of these symptoms. They were currently looking at tackling the MCAS issue, which they called low-hanging fruit, and said KPV sounded well tolerated.
Ask Miruvor AI
What they tried
Also tried
Their words about each treatment
- LDN · Worse
Just .01 mg of LDN was enough to set my system off. Insomnia, dysautonomia, PEM, MCAS, and fatigue issues all get worse.
In context ↗
Their path
They say too little about how ill they were at each step to draw it on the severity scale, so the steps are listed as they describe them. Dates are when they posted.
| When | What happened | After |
|---|---|---|
| 2026-05-29 | 0.01 mg LDN set system off and worsened insomnia, dysautonomia, PEM, MCAS and fatigue.01 mg of LDN was enough to set my system off. ... Insomnia, dysautonomia, PEM, MCAS, and fatigue issues all get worse.In context ↗ | Low-dose naltrexone |
| 2026-05-29 | Still symptomatic; considering MCAS treatmentI'm currently looking at tackling the MCAS issue as it seems like low-hanging fruitIn context ↗ |
Adverse events
- Low-dose naltrexone“Just .01 mg of LDN was enough to set my system off. Insomnia, dysautonomia, PEM, MCAS, and fatigue issues all get worse.” In context ↗ Made symptoms worse